|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Total net revenues | |||||
| Net revenues and financial income | |||||
| Net service revenues and financial income | |||||
| Net product revenues | |||||
| Total net revenues and financial income | |||||
| Cost of net revenues and financial expenses | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Product and technology development | |||||
| Sales and marketing | |||||
| Provision for doubtful accounts | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (expenses): | |||||
| Interest income and other financial gains, net | |||||
| Interest expense and other financial losses | |||||
| Foreign currency losses, net | |||||
| Net income before income tax expense and equity in earnings of unconsolidated entity | |||||
| Income tax expense | |||||
| Equity in earnings of unconsolidated entity | |||||
| Net income | |||||
| Basic earnings per share | |||||
| Basic net income available to shareholders per common share (in dollars per share) | |||||
| Weighted average of outstanding common shares (in shares) | |||||
| Diluted earnings per share | |||||
| Diluted net income available to shareholders per common share (in dollars per share) | |||||
| Weighted average of outstanding common shares (in shares) | |||||
Loading...